Kyto Technology and Life Science, Inc. (KBPH) Research

Kyto Technology and Life Science, Inc. operates as a venture capital firm, primarily targeting nascent and early-stage enterprises. Its investment focus lies specifically within the technology and life science sectors. The firm's funding approach offers two main options: either secured convertible debt (which accrues interest and includes a conversion discount into preferred equity) or direct investment in preferred shares. Notably, Kyto Technology and Life Science does not take the lead role in financing rounds. Its investment capital is geographically distributed, with half allocated to ventures in the United States and the remainder supporting companies in Canada and Israel. Established in 1999, the company was formerly known as Kyto BioPharma, Inc. before rebranding in April 2018. It maintains its headquarters in Los Altos Hills, California, with a secondary office located in Scotts Valley, California.

Market snapshot

Symbol
KBPH
Price
$1.00
Day change
-45.65%
Market cap
$13.3M
P/E ratio
15.94x
52-week range
1.0-1.0
Sector
Financial Services
Industry
Asset Management

Peer companies

  • ADVFN Plc (AVFCF)
  • China United Insurance Service, Inc. (CUII)
  • Bellatora Inc. (ECGR)
  • Midland Capital Holdings Corp. (MCPH)
  • NextPoint Financial Inc. (NACQF)
  • Profusa, Inc. Common Stock (PFSA)
  • Reservoir Capital Corp. (RSERF)
  • Sentry Select Primary Metals Corp. (SPMLF)

Recent insider activity

  • BENARROCH GEORGES — M-Exempt (181250 shares) on 2021-03-16
  • BENARROCH GEORGES — M-Exempt (181250 shares) on 2021-03-16
  • BENARROCH GEORGES — A-Award (50000 shares) on 2020-07-20
  • BENARROCH GEORGES — A-Award (150000 shares) on 2019-10-10
  • COMINDUS FINANCE CORP. — J-Other (400000 shares) on 2018-04-25

Open Kyto Technology and Life Science, Inc. (KBPH) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.